Back to Search
SUZANNE GEORGE, MD
MD
Medical Oncology Physician
NPI: 1437126018IndividualAccepts Medicare
Specialties, Licenses & Credentials
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
203052(MA)
CMS Specialties
PrimaryHEMATOLOGY/ONCOLOGY
Education
UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL
Class of 1995
Research & Publications (20)
Multicenter phase II trial of sunitinib in the treatment of nongastrointestinal stromal tumor sarcomas.
PMID 19451429·J Clin Oncol·2009
3-trial
Clinical evaluation of continuous daily dosing of sunitinib malate in patients with advanced gastrointestinal stromal tumour after imatinib failure.
PMID 19282169·Eur J Cancer·2009
3-trial
Sunitinib, a multitargeted tyrosine kinase inhibitor, in the management of gastrointestinal stromal tumor.
PMID 17588358·Curr Oncol Rep·2007
6-review
Selective kinase inhibition with daily imatinib intensifies toxicity of chemotherapy in patients with solid tumours.
PMID 16503137·Eur J Cancer·2006
8-other
Current management of metastatic gastrointestinal stromal tumor: a case report.
PMID 16227963·Clin Adv Hematol Oncol·2003
5-case
Management of gastrointestinal stromal tumors in the era of tyrosine kinase inhibitors.
PMID 12392638·Curr Treat Options Oncol·2002
6-review
Analysis of rhamnolipid biosurfactants produced through submerged fermentation using orange fruit peelings as sole carbon source.
PMID 18716921·Appl Biochem Biotechnol·2009
8-other
Isolation and characterization of an atypical LEA protein coding cDNA and its promoter from drought-tolerant plant Prosopis juliflora.
PMID 19002660·Appl Biochem Biotechnol·2009
8-other
Photodimerization processes in self-assembled chiral oligo(p-phenylenevinylene) bolaamphiphiles.
PMID 19360769·Chem Asian J·2009
8-other
Synthesis and evaluation of the biological activities of some 3-{[5-(6-methyl-4-aryl-2-oxo-1,2,3,4-tetrahydropyrimidin-5-yl)-1,3,4-oxadiazol-2-yl]-imino}-1,3-dihydro-2H-indol-2-one derivatives.
PMID 18337213·Acta Pharm·2008
8-other
Phase I/II trial of 5-fluorouracil and a noncytotoxic dose level of suramin in patients with metastatic renal cell carcinoma.
PMID 18824429·Clin Genitourin Cancer·2008
3-trial
Dermatological conditions in intensive care: a secondary analysis of the Intensive Care National Audit and Research Centre (ICNARC) Case Mix Programme database.
PMID 19105799·Crit Care·2008
4-observational
Phase I trial of PEG-interferon and recombinant IL-2 in patients with metastatic renal cell carcinoma.
PMID 17909807·Cancer Chemother Pharmacol·2008
3-trial
A novel dopamine receptor signaling unit in brain: heterooligomers of D1 and D2 dopamine receptors.
PMID 17982577·ScientificWorldJournal·2007
6-review
Helicity induction and amplification in an oligo(p-phenylenevinylene) assembly through hydrogen-bonded chiral acids.
PMID 17886328·Angew Chem Int Ed Engl·2007
8-other
Ramsey method of separated oscillatory fields for high-precision penning trap mass spectrometry.
PMID 17501414·Phys Rev Lett·2007
8-other
Identification of stress-induced genes from the drought-tolerant plant Prosopis juliflora (Swartz) DC. through analysis of expressed sequence tags.
PMID 17612616·Genome·2007
8-other
In Silico Modeling of Respiratory Structure, Function, and Disease.
PMID 19568329·Drug Discov Today Dis Models·2007
8-other
Comparative extreme ultraviolet emission measurements for lithium and tin laser plasmas.
PMID 17375180·Opt Lett·2007
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 44 BINNEY ST, DANA FARBER CANCER INSTITUTE CENTER FOR SARCOMA SW530
BOSTON, MA 02115 - Phone
- (617) 632-5204
Quick Facts
- NPI
- 1437126018
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 31
- Publications
- 20
Are you this provider?
Claim Your Profile